home

clinical

refractive

Clinical

Articles

Kathryn M. Hatch, MD, details how collagen CXL is evolving with the goals of reducing complications and actually improving visual acuity.

Exploring collagen cross-linking as a treatment for keratoconus

Dr. Devgan, assistant clinical professor, Jules Stein Eye Institute, University of California, Los Angeles.

Podcasts

Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.

What patients need to know about cataract surgery

Investigators find little difference between the options.

IOL dilemma: Replacement or rescue 

Videos

In recognition of Cataract Awareness Month. 

Looking at technological advancements in cataract surgery

Lens option can correct for surgically induced astigmatism or an inaccurate position.

Light adjustable IOLs: Treat patients with Star Trek-like technology

Cuttitta is head of ophthalmology at Clinica Andros in Palermo, Italy. He has no financial disclosures related to this article.

Bi-sign design compensates for aberrations resulting from misalignment.

Examining stability of aspheric IOL in cataract patients 

Barberá is a cataract and refractive surgeon and glaucoma specialist at Oftalvist Madrid and Moncloa HLA Hospital, Madrid, Spain. She has no financial disclosures to make.

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.

Benefits of topography-guided treatments for irregular corneas

Therapeutic choices beneficial for patients may be available in 1 to 3 years.

New options are on horizon for presbyopia-correcting drops

Investigators examine the demographic, refractive, PRO data measure.

Predicting laser vision correction results

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Patients are serious about procedure and ready to move forward.

Refractive surgeons report boost in patient interest during the COVID-19 era

Refractive Surgery

Refractive

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of 

for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of 

Ophthalmology Times, Ophthalmology Times Europe, Modern Retina 

 Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s 

Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for 

 Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Cathleen McCabe, MD, discusses VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, and how it provides opportunities for patients looking for spectacle independence.

FDA-approved eye drops target presbyopia patients

Piñero is a senior researcher and lecturer from the same group and is responsible for the advanced optometry unit of the Department of Ophthalmology of Vithas Medimar International Hospital, Alicante, Spain. 

Bataille is a post-doctoral researchers from the Group of Optics and Visual Perception of the Department of Optics, Pharmacology and Anatomy, University of Alicante, Spain.

Molina-Martín is a post-doctoral researcher from the Group of Optics and Visual Perception of the Department of Optics, Pharmacology and Anatomy, University of Alicante, Spain.

Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.

The relationship between myopia and conjunctival-scleral geometry

George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.